scholarly journals Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial

2019 ◽  
Vol 10 (25) ◽  
pp. 6185-6190
Author(s):  
Seung Tae Kim ◽  
Sung Yong Oh ◽  
Jeeyun Lee ◽  
Jung Hun Kang ◽  
Hyun Woo Lee ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Biliary Tract Cancers ◽  
Line Therapy ◽  
Open Label Phase

scholarly journals Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study

2013 ◽  
Vol 49 (16) ◽  
pp. 3412-3419 ◽  
Author(s):  
Jordi Bruix ◽  
Won-Young Tak ◽  
Antonio Gasbarrini ◽  
Armando Santoro ◽  
Massimo Colombo ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Safety Study ◽  
Line Therapy ◽  
Open Label Phase

Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma

2006 ◽  
Vol 25 (3) ◽  
pp. 265-270 ◽  
Author(s):  
Matthew D. Galsky ◽  
Svetlana Mironov ◽  
Alexia Iasonos ◽  
Joseph Scattergood ◽  
Mary G. Boyle ◽  
...  
Keyword(s):  
Urothelial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Metastatic Urothelial Carcinoma
Sign in / Sign up

Export Citation Format

Share Document